BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37443791)

  • 21. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
    Wise LE; Long KA; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
    ACS Chem Neurosci; 2012 May; 3(5):369-78. PubMed ID: 22860205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.
    Lysenko LV; Kim J; Henry C; Tyrtyshnaia A; Kohnz RA; Madamba F; Simon GM; Kleschevnikova NE; Nomura DK; Ezekowitz RA; Kleschevnikov AM
    PLoS One; 2014; 9(12):e114521. PubMed ID: 25474204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JZL184, A Monoacylglycerol Lipase Inhibitor, Induces Bone Loss in a Multiple Myeloma Model of Immunocompetent Mice.
    Marino S; Carrasco G; Li B; Shah KM; Lath DL; Sophocleous A; Lawson MA; Idris AI
    Calcif Tissue Int; 2020 Jul; 107(1):72-85. PubMed ID: 32285169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice.
    Owens RA; Ignatowska-Jankowska B; Mustafa M; Beardsley PM; Wiley JL; Jali A; Selley DE; Niphakis MJ; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2016 Aug; 358(2):306-14. PubMed ID: 27307500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
    Guindon J; Guijarro A; Piomelli D; Hohmann AG
    Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoacylglycerol Lipase (MAGL) Inhibition Impedes the Osteosarcoma Progression by Regulating Epithelial Mesenchymal Transition.
    Gong X; Zheng X; Huang Y; Song W; Chen G; Chen T
    Tohoku J Exp Med; 2022 Jan; 256(1):19-26. PubMed ID: 35067491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of monoacylglycerol lipase is associated with passive coping behavior and attenuation of stress-induced dopamine release in the medial prefrontal cortex.
    Pavón FJ; Polis IY; Stouffer DG; Cravatt BF; Roberto M; Martin-Fardon R; Rodríguez de Fonseca F; Parsons LH; Serrano A
    Neurobiol Stress; 2021 May; 14():100293. PubMed ID: 33490317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
    Hruba L; Seillier A; Zaki A; Cravatt BF; Lichtman AH; Giuffrida A; McMahon LR
    J Pharmacol Exp Ther; 2015 May; 353(2):261-8. PubMed ID: 25711338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
    Aymerich MS; Rojo-Bustamante E; Molina C; Celorrio M; Sánchez-Arias JA; Franco R
    Mol Neurobiol; 2016 May; 53(4):2312-9. PubMed ID: 25976369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexually dimorphic effects of monoacylglycerol lipase inhibitor MJN110 on stress-related behaviour and drinking in Marchigian Sardinian alcohol-preferring rats.
    Vozella V; Cruz B; Feldman HC; Bullard R; Bianchi PC; Natividad LA; Cravatt BF; Zorrilla EP; Ciccocioppo R; Roberto M
    Br J Pharmacol; 2023 Dec; 180(24):3130-3145. PubMed ID: 37488777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice.
    Trigo JM; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1815-22. PubMed ID: 26490035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Kinsey SG; O'Neal ST; Long JZ; Cravatt BF; Lichtman AH
    Pharmacol Biochem Behav; 2011 Mar; 98(1):21-7. PubMed ID: 21145341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.
    Kinsey SG; Nomura DK; O'Neal ST; Long JZ; Mahadevan A; Cravatt BF; Grider JR; Lichtman AH
    J Pharmacol Exp Ther; 2011 Sep; 338(3):795-802. PubMed ID: 21659471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.
    Schlosburg JE; Kinsey SG; Ignatowska-Jankowska B; Ramesh D; Abdullah RA; Tao Q; Booker L; Long JZ; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2014 Aug; 350(2):196-204. PubMed ID: 24849924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice.
    von Rüden EL; Bogdanovic RM; Wotjak CT; Potschka H
    Neurobiol Dis; 2015 May; 77():238-45. PubMed ID: 25796567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.
    Marino S; de Ridder D; Bishop RT; Renema N; Ponzetti M; Sophocleous A; Capulli M; Aljeffery A; Carrasco G; Gens MD; Khogeer A; Ralston SH; Gertsch J; Lamoureux F; Heymann D; Rucci N; Idris AI
    EBioMedicine; 2019 Jun; 44():452-466. PubMed ID: 31151929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A; Okine BN; Finn DP; Masocha W
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.